Buying and Distributing A COVID-19 Vaccine will Involve Hard Ethical and Practical Choices
Barbara Allen and
The Conversation | November 18, 2020
The world was ablaze with hope following the announcement last week that a vaccine developed by Pfiser and BioNTech may be more than 90% effective in preventing COVID-19.
New Zealand politicians were quick to point out 1.5 million doses had already been pre-purchased through a legally binding agreement signed in late September to buy any vaccine to emerge from the multilateral COVAX facility.Read More »